Palindromic Labs is a preclinical phase drug discovery company, narrowly focusing on the drug space with proven biology – we do not expend our efforts on discovering new biological processes; with sufficient data to harness the power of AI for optimization – we do not intend to be a pure chemist designer; with verifiable efficacy by high-throughput screening processes – we do not take just a few shots. Palindromic Labs strives to attain higher success rates and better return on investment than the industry norms.